CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 62 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,754,000 | -16.1% | 701,318 | -0.3% | 0.01% | -60.0% |
Q2 2021 | $2,091,000 | -15.5% | 703,248 | -0.1% | 0.02% | -16.7% |
Q1 2021 | $2,475,000 | -26.2% | 703,826 | -0.3% | 0.02% | -35.1% |
Q4 2020 | $3,352,000 | +9.9% | 705,823 | +12.4% | 0.04% | -9.8% |
Q3 2020 | $3,051,000 | +144.7% | 627,949 | +63.6% | 0.04% | +95.2% |
Q2 2020 | $1,247,000 | -60.3% | 383,910 | -37.4% | 0.02% | -67.2% |
Q1 2020 | $3,139,000 | +16.2% | 613,439 | +3.6% | 0.06% | +52.4% |
Q4 2019 | $2,701,000 | -20.3% | 592,079 | +6.9% | 0.04% | -20.8% |
Q3 2019 | $3,388,000 | +20.7% | 553,770 | +20.1% | 0.05% | +26.2% |
Q2 2019 | $2,806,000 | +15.0% | 460,956 | +4.8% | 0.04% | +10.5% |
Q1 2019 | $2,441,000 | +23.7% | 439,778 | +26.1% | 0.04% | +11.8% |
Q4 2018 | $1,973,000 | – | 348,627 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
Virtu Financial LLC | 19,653 | $49,000 | 0.00% |